Skip to main content

Table 3 Risk factors for death within 30 days after Enterococcus faecium bacteraemia (Cox regression; n = 177)

From: Does vancomycin resistance increase mortality in Enterococcus faecium bacteraemia after orthotopic liver transplantation? A retrospective study

 UnivariateMultivariate
VariablesDead
n = 21
Alive
n = 156
HR95% CIpHR95% CIp
Definitive infectious focus elimination
 Yes6 (28.6)40 (25.6)0.850.33–2.200.7450.500.19–1.370.181
 No15 (71.4)116 (74.4)      
Start of adequate AB Therapy within < 48 h post-BSI onset
 Yes14 (66.7)90 (57.7)1.470.59–3.640.4071.030.39–2.740.952
 No7 (33.3)66 (42.3)      
Mean SOFANon-GCS (day-7 until day-1 before BSI onset)12.8 ± 3.86.8 ± 4.71.301.16–1.46< 0.0011.321.14–1.53< 0.001
ICU stay between day-7 and BSI onset [days]7.6 ± 1.25.0 ± 3.51.471.08–2.000.0141.010.71–1-440.966
Bacteraemia
 VRE6 (15.4)33 (84.6)1.490.58–3.840.4091.800.64–5.030.264
 VSE15 (10.9)123 (89.1)      
  1. Data are presented as n (%) or mean ± standard deviation.
  2. Abbreviations: HR hazards ratio, CI confidence interval, AB antibiotic therapy, BSI bloodstream infection, SOFA sequential organ failure assessment, GCS Glasgow coma scale, VRE vancomycin-resistant Enterococcus faecium, VSE vancomycin-susceptible Enterococcus faecium